Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
45.44
-0.92 (-1.98%)
Jul 15, 2026, 4:00 PM EDT - Market closed
Spruce Biosciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
14
Market Cap
125.06M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 4.91M | -5.18M | -51.32% |
| Dec 31, 2023 | 10.09M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Agenus | 123.87M |
| Coya Therapeutics | 7.94M |
| Cibus | 4.29M |
| Molecular Partners AG | 856.30K |
| Genelux | 8.00K |
| Fractyl Health | 3.00K |
SPRB News
- 2 days ago - Spruce Biosciences initiated with a Buy at B. Riley - TheFly
- 7 days ago - Spruce Biosciences to Participate in the B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit - Business Wire
- 16 days ago - Spruce Biosciences joins Russell 3000 Index - TheFly
- 16 days ago - Spruce Biosciences Joins the Russell 3000® Index - Business Wire
- 23 days ago - Spruce Biosciences appoints Agnieszka Jurecka as VP, medical affairs - TheFly
- 23 days ago - Spruce Biosciences Appoints Agnieszka Jurecka, M.D., Ph.D., MPH, as Vice President, Medical Affairs - Business Wire
- 4 weeks ago - Spruce Biosciences initiated with a Buy at Guggenheim - TheFly
- 4 weeks ago - Spruce Biosciences names Eric Jordan VP, marketing, Tina Gullotta VP, finance - TheFly